Tag: Roche

May 25, 2017 Off

FDA OK’s Roche’s arteritis drug

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has approved Roche’s Actemra/RoActemra (tocilizumab) subcutaneous injection for the treatment of GCA, a chronic and severe autoimmune condition.

April 11, 2017 Off

Roche’s Alecensa beats crizotinib in certain lung cancer

By Dino Mustafić

Roche’s randomised phase III ALEX study showed that Alecensa (alectinib) as an initial (first-line) treatment significantly reduced the risk of disease worsening or death (progression-free survival, PFS) compared to crizotinib in people with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).